| TF Name |
Cell-line |
Condition/Source |
Collections |
Species |
Identifiers |
JASPAR ID |
| GATA2 |
3T3-L1 (embryonic fibroblasts) |
PAssage: 4-6 |
Permissive
Robust
|
Mus musculus |
GSE101592
...
|
MA0036.3
|
| GATA2 |
3T3-L1 (embryonic fibroblasts) |
PAssage: 4-6 |
Permissive
Robust
|
Mus musculus |
GSE101592
...
|
MA0036.3
|
| GATA2 |
C3H10T1/2 (embryonic fibroblasts) |
PAssage: 4-6 |
Permissive
Robust
|
Mus musculus |
GSE101592
...
|
MA0036.3
|
| GATA2 |
C3H10T1/2 (embryonic fibroblasts) |
PAssage: 4-6 |
Permissive
Robust
|
Mus musculus |
GSE101592
...
|
MA0036.3
|
| GATA2 |
TF-1 (erythroleukemia) |
Genotype: wildtype; Treatment: DOX for 6 days; |
Permissive
Robust
|
Homo sapiens |
GSE73207
...
|
MA0036.3
|
| GATA2 |
TF-1 (erythroleukemia) |
Genotype: TF-1-RAD21 Q592*; Treatment: DOX for 6 days; |
Permissive
|
Homo sapiens |
GSE73207
...
|
MA0036.3
|
| GATA2 |
TF-1 (erythroleukemia) |
Genotype: TF-1-RAD21 Q592*; Treatment: DOX for 6 days; |
Permissive
|
Homo sapiens |
GSE73207
...
|
MA0036.3
|
| GATA2 |
ME-1 (acute myeloid leukemia ) |
Treatment: 600 ng/ml doxycycline; Genotype: CBFB-MYH11 knockdown construct, GATA2 knockdown; |
Permissive
|
Homo sapiens |
GSE117138
...
|
MA0036.3
|
| GATA2 |
K562 (myelogenous leukemia) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000BKM
|
MA0036.3
|
| GATA2 |
K562 (myelogenous leukemia) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000DKA
|
MA0036.3
|
Showing 10 records in page 387
from 963 pages